Crossover I. Scsp Nextech - 20 Dec 2024 Form 3 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Reporting relationship: 10%+ Owner
Issuer ticker: MRSN
Reported as of: 20 Dec 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 30 Dec 2024, 16:12:17 UTC
Source filing: View source filing
Reporting owner signature: Nextech Crossover I SCSp, By Nextech Crossover I GP S.a r.l., its General Partner, By /s/ Ian Charoub and /s/ Costas Constantinides, Managers

Key filing fact

Crossover I. Scsp Nextech filed Form 3 for Mersana Therapeutics, Inc. (MRSN) on 30 Dec 2024.

Key facts

This page summarizes Crossover I. Scsp Nextech's Form 3 filing for Mersana Therapeutics, Inc. (MRSN).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 30 Dec 2024, 16:12.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRSN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 12,067,246
Date: 20 Dec 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The securities are held of record by Nextech Crossover I SCSp ("Nextech Crossover LP"). Nextech Crossover I GP S.a. r.l. ("Nextech Crossover GP") is the general partner of Nextech Crossover LP and Ian Charoub, Costas Constantinides and Rocco Sgobbo are Managers of Nextech Crossover GP. Nextech Crossover GP and Messrs. Charoub, Constantinides and Sgobbo may be deemed to share voting and investment power with respect to the securities reported herein and disclaim beneficial ownership over such securities, except to the extent of its or his respective pecuniary interest therein, if any.

SEC remarks

The Reporting Persons became the beneficial owners of greater than 10% of the Issuer's outstanding common stock as a result of a decrease in the number of shares outstanding, as described in the Issuer's Current Report on Form 8-K filed with the SEC on December 19, 2024, and not as a result of the acquisition of any securities by the Reporting Persons.